title: Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned.
authors.affiliation: Department of Molecular and Clinical Pharmacology, University of Liverpool, UK.
authors.forename: David J
authors.initials: DJ
authors.lastname: Back
authors.affiliation: Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: david.burger@radboudumc.nl.
authors.forename: David M
authors.initials: DM
authors.lastname: Burger
mesh_terms: D000638:Amiodarone / Q000008:administration & dosage*; D001919:Bradycardia / Q000139:chemically induced*; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D000069474:Sofosbuvir / Q000009:adverse effects*
chemical_list: D007093:Imidazoles; D000638:Amiodarone; D000069474:Sofosbuvir